NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.

NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.

Modification in the function of dendritic cells (DC), such as that achieved by microbial stimuli or T cell help, plays a critical role in determining the quality and size of adaptive responses to Ag. NKT cells bearing an invariant TCR (iNKT cells) restricted by nonpolymorphic CD1d molecules may cons...

Bibliografske podrobnosti
Main Authors:	Hermans, I, Silk, J, Gileadi, U, Salio, M, Mathew, B, Ritter, G, Schmidt, R, Harris, A, Old, L, Cerundolo, V
Format:	Journal article
Jezik:	English
Izdano:	2003

Podobne knjige/članki

Dendritic cell function can be modulated through cooperative actions of TLR ligands and invariant NKT cells.
od: Hermans, I, et al.
Izdano: (2007)

CpG-matured murine plasmacytoid dendritic cells are capable of in vivo priming of functional CD8 T cell responses to endogenous but not exogenous antigens.
od: Salio, M, et al.
Izdano: (2004)

Nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells
od: Silk, J, et al.
Izdano: (2008)

Cutting edge: nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells.
od: Silk, J, et al.
Izdano: (2008)

Harnessing invariant NKT cells in vaccination strategies.
od: Cerundolo, V, et al.
Izdano: (2009)

Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy
od: Silk, J, et al.
Izdano: (2004)

Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy.
od: Silk, J, et al.
Izdano: (2004)

Nonglycosidic agonists of invariant NKT cells for use as vaccine adjuvants.
od: Reddy, BG, et al.
Izdano: (2009)

B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo.
od: Barral, P, et al.
Izdano: (2008)

The actin cytoskeleton modulates the activation of invariant NKT cells by segregating CD1d nanoclusters on antigen presenting cells
od: Cerundolo, V, et al.
Izdano: (2016)

A closer look at CD1d molecules: new horizons in studying NKT cells.
od: Stronge, V, et al.
Izdano: (2007)

Harnessing NKT cells for therapeutic applications.
od: Cerundolo, V, et al.
Izdano: (2007)

Increasing the survival of dendritic cells in vivo does not replace the requirement for CD4+ T cell help during primary CD8+ T cell responses.
od: Matthews, K, et al.
Izdano: (2007)

Mature dendritic cells differentiated in the presence of interferon-beta and interleukin-3 prime functional antigen-specific CD8 T cells.
od: Renneson, J, et al.
Izdano: (2005)

Immunization with a lentivector that targets tumor antigen expression to dendritic cells induces potent CD8+ and CD4+ T-cell responses.
od: Lopes, L, et al.
Izdano: (2008)

Constitutive crosspresentation of tissue antigens by dendritic cells controls CD8+ T cell tolerance in vivo.
od: Luckashenak, N, et al.
Izdano: (2008)

Recent advances in processing and presentation of CD1 bound lipid antigens.
od: Salio, M, et al.
Izdano: (2010)

Biology of CD1- and MR1-restricted T cells.
od: Salio, M, et al.
Izdano: (2014)

Regulation of hematopoiesis in vitro and in vivo by invariant NKT cells.
od: Kotsianidis, I, et al.
Izdano: (2006)

Invariant NKT Cell at the Interface between Innate and Adaptive Immunity
od: Salio, M, et al.
Izdano: (2011)

The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation.
od: McCarthy, C, et al.
Izdano: (2007)

The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo.
od: Hermans, I, et al.
Izdano: (2004)

Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141 XCR1 dendritic cells
od: Silk, K, et al.
Izdano: (2012)

Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141(+)XCR1+ dendritic cells.
od: Silk, K, et al.
Izdano: (2012)

Regulation of hematopoiesis in vitro and in vivo by invariant NKT cells.
od: Kotsianidis, I, et al.
Izdano: (2005)

CD8+ T-cell immunity orchestrated by iNKT cells
od: Yingyu Qin, et al.
Izdano: (2023-01-01)

CTL priming by CD8(+) and CD8(-) dendritic cells in vivo.
od: Ruedl, C, et al.
Izdano: (1999)

Dendritic cells: a journey from laboratory to clinic.
od: Cerundolo, V, et al.
Izdano: (2004)

The role of invariant NKT cells in enhancing antigen specific T and B cell responses
od: Cerundolo, V
Izdano: (2005)

CD169(+) macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes.
od: Barral, P, et al.
Izdano: (2010)

Globosides but not isoglobosides can impact the development of invariant NKT cells and their interaction with dendritic cells.
od: Porubsky, S, et al.
Izdano: (2012)

CD8(+) T cells mediate CD40-independent maturation of dendritic cells in vivo.
od: Ruedl, C, et al.
Izdano: (1999)

Activation of human mucosal-associated invariant T cells induces CD40L-dependent maturation of monocyte-derived and primary dendritic cells
od: Salio, M, et al.
Izdano: (2018)

Harnessing invariant NKT-cells to enhance antigen specific immune responses
od: Cerundolo, V
Izdano: (2014)

CD4(-)CD8alphaalpha subset of CD1d-restricted NKT cells controls T cell expansion.
od: Ho, L, et al.
Izdano: (2004)

Antitumor Immunity Produced by the Liver Kupffer Cells, NK Cells, NKT Cells, and CD8+ CD122+ T Cells
od: Shuhji Seki, et al.
Izdano: (2011-01-01)

A dominant role for the immunoproteasome in CD8+ T cell responses to murine cytomegalovirus.
od: Hutchinson, S, et al.
Izdano: (2011)

Diverse endogenous antigens for mouse NKT cells: self-antigens that are not glycosphingolipids.
od: Pei, B, et al.
Izdano: (2011)

The role of DOCK8 in the maintenance of CD8+ T cell memory and invariant NKT cells
od: Crawford, G
Izdano: (2012)

Quantitative contribution of CD4 and CD8 to T cell antigen receptor serial triggering.
od: Viola, A, et al.
Izdano: (1997)